Awarded Contractocds-tedeu-1ecfbb8b-804e-4360-b76d-d4c335939d48

Suministro del medicamento exclusivo: Ravulizumab (ULTOMIRIS).

Suministro del medicamento exclusivo: Ravulizumab (ULTOMIRIS).

Buyer

Servicio Madrileño de Salud - Hospital Universitario La Paz

Value

€2,603,216

Published

9 Sept 2026

Closes

Not provided

Procurement details

Source

TED (EU)

Country

Spain (ES)

Procurement method

Limited

Category

Goods

Contract starts

Not provided

Contract ends

Not provided

CPV classifications

33600000

Pharmaceutical products

Lots

Lot LOT-0001 Suministro del medicamento exclusivo: Ravulizumab (ULTOMIRIS).

€2,603,216

Suministro del medicamento exclusivo: Ravulizumab (ULTOMIRIS).

Delivery: Madrid · ES300 · Spain

Documents

Unlock document link

TED notice 620013-2026

9 Sept 2026

Award notice · Web page

Contains information from TED (Tenders Electronic Daily), © European Union, reused under CC BY 4.0.